Teva Pharmaceutical (TEVA) Tops Q3 EPS by 1c

October 31, 2013 8:53 AM

Teva Pharmaceutical (NYSE: TEVA) reported Q3 EPS of $1.27, $0.01 better than the analyst estimate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found